Laxana-8 Soft Gel Capsule Capsule

About Laxana-8 Soft Gel Capsule

Laxana-8 Soft Gel Capsule is a branded medicine containing lubiprostone 8 mcg, used for certain long-term constipation problems and irritable bowel syndrome with constipation in adults. It is a locally acting laxative that helps increase intestinal fluid and movement.

There are 4 brands of Lubiprostone listed in Bangladesh.

What is Laxana-8 Soft Gel Capsule?

Laxana-8 Soft Gel Capsule is a soft gel capsule containing lubiprostone 8 mcg, made by Renata PLC. It belongs to a group of laxative preparations that work locally in the intestine. It increases secretion of chloride and fluid into the bowel, which helps stool pass more easily. Doctors prescribe it for irritable bowel syndrome with constipation and for certain types of ongoing constipation in adults. The dose and course are decided by the doctor based on the patient's condition. It is not for use in people with suspected or known bowel obstruction.

Uses of Laxana-8 Soft Gel Capsule

Laxana-8 Soft Gel Capsule is used in adults for irritable bowel syndrome with constipation (IBS-C), chronic idiopathic constipation (CIC), and opioid-induced constipation (OIC) in patients with long-term non-cancer pain. It is a locally acting laxative that helps relieve constipation by increasing fluid in the intestine. The doctor decides whether it is suitable for a particular person and for how long it should be taken.

How to use Laxana-8 Soft Gel Capsule

Take Laxana-8 Soft Gel Capsule by mouth with food and water, as directed by the doctor. Swallow the soft gel capsule whole; do not crush or chew it unless the doctor or pharmacist says otherwise. The dose and how often to take it are decided by the doctor and depend on the condition being treated. Do not change the dose or stop the medicine without asking the doctor. If you miss a dose, ask the doctor or pharmacist what to do.

Side effects of Laxana-8 Soft Gel Capsule

People taking Laxana-8 Soft Gel Capsule may experience diarrhea, nausea, stomach pain, a full or bloated feeling, swelling of the stomach area, or shortness of breath. Taking the capsule with food may help reduce nausea. If diarrhea is severe or does not stop, or if you have other troublesome symptoms, contact the doctor. The doctor can advise whether the medicine needs to be adjusted or stopped. Do not treat side effects with other medicines without asking a pharmacist first.

Safety and precautions

Laxana-8 Soft Gel Capsule should not be used if there is a known or suspected mechanical bowel obstruction. Tell the doctor if you have severe diarrhea before starting this medicine. If you are pregnant, planning pregnancy, or breastfeeding, ask the doctor before using it; it is pregnancy category C and it is not known if it passes into breast milk, so breastfed babies should be monitored for diarrhea. People with liver problems should have their dose decided by the doctor. Keep all medicines out of reach of children and store as directed on the pack.

Frequently asked questions

What does the 8 mcg strength and soft gel capsule form mean?

The strength 8 mcg means each soft gel capsule contains 8 micrograms of lubiprostone. A soft gel capsule is a small, soft shell that is swallowed whole. The doctor will decide the dose and how often you should take it; do not change it yourself.

What is Laxana-8 Soft Gel Capsule used for and what kind of medicine is it?

It is used in adults for irritable bowel syndrome with constipation, chronic idiopathic constipation, and opioid-induced constipation in people with long-term non-cancer pain. It is a locally acting laxative that increases fluid secretion in the intestine. The doctor decides if it is right for you.

Which medicines may interact with Laxana-8 Soft Gel Capsule?

There is a possibility that medicines called diphenylheptane opioids may reduce how well lubiprostone works, in a dose-dependent way. Tell your doctor or pharmacist about all medicines you take, including opioids, so they can check for interactions and advise you.

What should I do if I have diarrhea while taking this medicine?

Diarrhea is a possible side effect. If it is severe or does not stop, contact your doctor. Do not take other anti-diarrhea medicines without asking the doctor or pharmacist first. The doctor will decide whether the medicine needs to be adjusted or stopped.

Indications

Lubiprostone is indicated in:
  • Irritable Bowel Syndrome with Constipation (IBS-C).
  • Chronic Idiopathic Constipation (CIC) in adults.
  • Opioid-Induced Constipation (OIC) in adult patients with chronic, non-cancer pain.

Pharmacology

Lubiprostone is a locally-acting chloride-channel activator that increases intestinal secretion. In doing so, it increases intestinal motility, thus aiding the passage of stool and relieve the symptoms associated with chronic idiopathic constipation.

Lubiprostone acts by specifically activating ClC-2 chloride channels, which is a normal constituent of the apical membrane of the human intestine, in a protein kinase A action independent fashion. Activation of ClC-2 chloride channels causes an efflux of chloride ions into the lumen, which in turn leads to an efflux of sodium ions through a paracellular pathway to maintain isoelectric neutrality. As a result, water follows sodium into the lumen in order to maintain isotonic equilibrium, thereby increasing intestinal fluid secretion. By increasing intestinal fluid secretion, lubiprostone increases motility in the intestine, thereby increasing the passage of stool and alleviating symptoms associated with chronic idiopathic constipation. Activation of ClC-2 chloride channels may also stimulate the recovery of muscosal barrier function by restoring tight junction protein complexes in the intestine. Patch clamp cell studies in human cell lines have indicated that the majority of the beneficial biological activity of lubiprostone and its metabolites is observed only on the apical (luminal) portion of the gastrointestinal epithelium.

Dosage & Administration

Irritable Bowel Syndrome with Constipation: The recommended dose is 8 mcg twice daily orally with food and water.

Dosage in patients with hepatic impairment: Dosage adjustment is not required for patients with moderately impaired hepatic function. For patients with severely impaired hepatic function, the recommended starting dose is 8 mcg once daily. If tolerated then dose can be increased to 8 mcg twice 

Chronic Idiopathic Constipation and Opioid-induced Constipation: The recommended dose is 24 mcg twice daily orally with food and water. 

Dosage in patients with hepatic impairment: For patients with moderately impaired hepatic function, the recommended starting dose is 16 mcg twice daily. For patients with severely impaired hepatic function, the recommended starting dose is 8 mcg twice daily.

Interaction

There is a possibility of a dose-dependent decrease in the efficacy of Lubiprostone in patients using diphenylheptane opioids.

Contraindications

Lubiprostone is contraindicated in patients with known or suspected mechanical gastrointestinal obstruction.

Side Effects

Diarrhea, full or bloated feeling or pressure in the stomach, nausea, stomach pain, swelling of abdominal or stomach area, Dyspnea

Pregnancy & Lactation

Pregnancy category C. It is not known whether lubiprostone is excreted in human milk. Because lubiprostone increases fluid secretion in the intestine and intestinal motility, human milk-fed infants should be monitored for diarrhea. Caution should be exercised when Lubiprostone is administered to a nursing woman.

Precautions & Warnings

Nausea: Patients taking Lubiprostone may experience nausea. Concomitant administration of food with Lubiprostone may reduce symptoms of nausea.

Diarrhea: Lubistone should not be prescribed to patients that have severe diarrhea.

Bowel Obstruction: In patients with symptoms suggestive of mechanical gastrointestinal obstruction, perform a thorough evaluation to confirm the absence of an obstruction prior to initiating therapy with Lubiprostone.

Overdose Effects

Adverse reactions due to overdose may include: nausea, diarrhea, vomiting, dizziness, headache, abdominal pain, flushing/hot flash, retching, dyspnea, pallor, stomach discomfort, anorexia, asthenia , chest discomfort, dry mouth, hyperhidrosis , and syncope.

Storage Conditions

Store between 15-30° C.

Alternative brands of Lubiprostone

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.